SCHEMBL20425978

SCHEMBL20425978

Cc1ccc2c(c1)Sc1ccccc1N2CCCCN1CCC(N2CCOCC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 18/20 0.63
▸ LMNA P02545 1/20 0.45
▸ PGR P06401 1/20 0.45
▸ CHRM2 P08172 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ TBXA2R P21731 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ FPR2 P25090 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20425979 0.98 KDM1A (0.63) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20425964 0.94 KDM1A (0.63) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20425967 0.92 KDM1A (0.63) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL31673733 0.91 KDM1A (0.68) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20412079 0.91 KDM1A (0.68) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20425973 0.91 KDM1A (0.76) KDM1A
SCHEMBL20412075 0.90 KDM1A (0.70) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20412098 0.89 KDM1A (0.68) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL31673756 0.89 KDM1A (0.68) KDM1ALMNAPGRCHRM2HTR1A
SCHEMBL20425976 0.88 KDM1A (0.76) KDM1ALMNAPGRCHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035795-B1 Phenothiazine derivatives having CaM inhibitory activity KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-07-31 — — US disclosed
US-10035795-B1 Phenothiazine derivatives having CaM inhibitory activity KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035795-B1 Phenothiazine derivatives having CaM inhibitory activity CALM1, CAMK4, CAMK1 KDM1A 3642/4885LMNA 2841/4885PGR 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback